Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does REBIF Cause Malignant melanoma? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant melanoma have been filed in association with REBIF. This represents 0.3% of all adverse event reports for REBIF.

6
Reports of Malignant melanoma with REBIF
0.3%
of all REBIF reports
1
Deaths
1
Hospitalizations

How Dangerous Is Malignant melanoma From REBIF?

Of the 6 reports, 1 (16.7%) resulted in death, 1 (16.7%) required hospitalization.

Is Malignant melanoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for REBIF. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does REBIF Cause?

Multiple sclerosis relapse (158) Injection site erythema (137) Influenza like illness (128) Fatigue (123) Injection site pain (105) Headache (96) Injection site bruising (74) Pyrexia (74) Fall (73) Pneumonia (69)

What Other Drugs Cause Malignant melanoma?

SILDENAFIL (1,248) ADALIMUMAB (795) TADALAFIL (741) ETANERCEPT (495) INFLIXIMAB (478) METHOTREXATE (475) DABRAFENIB (402) LENALIDOMIDE (378) RANITIDINE (352) RITUXIMAB (291)

Which REBIF Alternatives Have Lower Malignant melanoma Risk?

REBIF vs REBOXETINE REBIF vs RECLAST REBIF vs RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E REBIF vs REGADENOSON REBIF vs REGORAFENIB

Related Pages

REBIF Full Profile All Malignant melanoma Reports All Drugs Causing Malignant melanoma REBIF Demographics